Quick Answer
Cytosorbents Corp reported Total Revenue of $22.50 million for the year ending 2018.
- Cytosorbents Corp showed an increase of +48.5% in Total Revenue from 2017 to 2018.
- This data is from Cytosorbents Corp's annual report (Form 10-K), filed with the SEC on March 7, 2019.
- XBRL data for this metric is available from 2011 to 2018 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2012: $16.9 thousand | Q2 2012: $33.0 thousand | Q1 2016: $1.81 million | Q2 2016: $2.22 million | Q3 2016: $2.41 million | Q4 2016: $3.08 million | Q1 2017: $3.11 million | Q2 2017: $3.57 million | Q3 2017: $3.82 million | Q4 2017: $4.65 million | Q1 2018: $4.92 million | Q2 2018: $5.76 million | Q3 2018: $5.74 million | Q4 2018: $6.08 million | Q1 2019: $5.19 million | Q2 2019: $6.23 million.
- Over the full 4 years of available data (2011 to 2018), Cytosorbents Corp's Total Revenue has grown by 62,275.7%.
- Historical annual values: Fiscal year 2018: $22.50 million | Fiscal year 2017: $15.15 million | Fiscal year 2016: $9.53 million | Fiscal year 2011: $36.1 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: